Sensorion Investor Relations Material
Latest events
Investor Update
Sensorion
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Sensorion SA
Access all reports
Sensorion SA is a clinical-stage biotechnology company focused on developing therapeutic solutions for inner ear disorders, particularly targeting hearing loss and balance disorders. The company's research and development efforts span from molecular biology to clinical research, aiming to address unmet medical needs related to inner ear pathologies. Sensorion's work includes developing drug treatments designed to restore, treat, and prevent these conditions, leveraging its expertise in animal pharmacology, toxicology, and clinical studies. The company is headquartered in Montpellier, France, and its shares are listed on the Euronext Paris.
Key slides for Sensorion SA
Corporate Presentation
Sensorion SA
Corporate Presentation
Sensorion SA
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
ALSEN
Country
🇫🇷 France